Caina Technology Co

Caina Technology Co Financing Cash Flow

The Net Financing Cash Flow of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is -51.96 M CNY. In the previous year, Net Financing Cash Flow was -42.88 M CNY — a change of 21.16% (lower).

Financing Cash Flow

-51.96 MCNY

YoY

21.16%

Last updated:

Net Financing Cash Flow of Caina Technology Co is 2024 -51.96 M CNY. Net Financing Cash Flow of Caina Technology Co was 2023 -42.88 M CNY. It decreases by 21.16% lower compared to the previous year.

The Caina Technology Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2017
1.46 M CNY
Jan 1, 2018
34.35 M CNY
Jan 1, 2019
-8.09 M CNY
Jan 1, 2020
-15.66 M CNY
Jan 1, 2021
-22.29 M CNY
Jan 1, 2022
1.07 B CNY
Jan 1, 2023
-42.88 M CNY
Jan 1, 2024
-51.96 M CNY
The Caina Technology Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
-51.96 MCNY+21.16%
-42.88 MCNY-104.02%
1.07 BCNY-4,886.58%
-22.29 MCNY+42.34%
-15.66 MCNY+93.65%
-8.09 MCNY-123.54%
34.35 MCNY+2,255.78%
1.46 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Net Financing Cash Flow of Caina Technology Co is -51.96 M CNY in 2024.

Net Financing Cash Flow of Caina Technology Co changed from -42.88 M CNY to -51.96 M CNY, representing a 21.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Caina Technology Co

All Key Metrics — Caina Technology Co